6/24/2023 0 Comments Rhythmstar heart monitorMany clients had trialed the device, and within a few weeks, were requesting more devices. In the first year the device came into the market, the company had projected to service 15,000 patients, but had significantly exceeded that amount by more than 7,000. In the video, see how RhythmStar can benefit both patients and physicians. “There is lots of information that says that patients should wear them longer to ensure it captures the arrhythmia accurately, and RhythmStar has a high diagnostic yield so the physician can figure out what is wrong with the patient and provide appropriate therapy such as ablation or medication,” Pike said. “Many traditional diagnostic devices that patients wear are only for a couple of days, while the RhythmStar can be worn for up to 30 days,” Brian Pike, co-managing principal for RhythMedix, told HCB News. The information is then sent to an independent diagnostic testing facility. The company had partnered with Microsoft Azure, a cloud computing platform built for building, deploying and managing applications and services, to allow physicians to access real-time patient information using a cloud-based algorithm analysis. The RhythmStar Remote Cardiac Monitoring System functions in three monitoring modes, Holter, which records a patient’s heart rhythm for one to two days Event, worn for 30 days by patients who have infrequent cases of arrhythmia and Mobile Cardiac Telemetry (MCT), which provides real-time monitoring and analysis by a registered nurse. have used the RhythmStar System, the first single component cloud-based cardiac monitoring solution. RhythmStar integrates seamlessly into clinical practice, helping physicians make informed treatment decisions that allow patients to enjoy life, without missing a beat.RhythMedix, a wireless medical arrhythmia monitoring company, announced that over 23,000 patients in the U.S. The sleek, one-piece device, with built-in 4G cellular technology, is the first wearable multi-modality cardiac monitor (Holter, Event and MCT) that connects patients and clinicians for improved patient care. "It also allows me to remain connected to my patients throughout their monitoring period, which may expedite a life-saving diagnosis." "The novel wearable RhythmStar monitoring device offers increased patient compliance and allows for accurate assessment of cardiac rhythm in real time," states Steven DaTorre, M.D., a Clinical Cardiologist at Cooper University Health Care in New Jersey. 1,2 While remote cardiac monitoring has improved arrhythmia detection, patient compliance and timely access to heart activity currently limit accurate and timely diagnosis. Heart arrhythmias are a major health concern that doubles the risk of death in an estimated 33.5 million people worldwide. RhythmStar is now available with HeartTime™ on-demand telemetry mode, an innovative platform that allows physicians to evaluate cardiac activity and expedite care via a telemedicine appointment, limiting the need for an in-person office visit. The technology enables rapid ECG analysis and reporting of cardiac abnormalities by RhythMedix's team of US-based certified technicians, who alert physicians if an arrhythmia of concern is detected. The novel cardiac telemetry monitor is discreetly worn for extended remote monitoring without the need for an additional phone or communication device. 18, 2021 /PRNewswire/ - RhythMedix, a leader in remote cardiac monitoring, today announced the release of its next-generation RhythmStar ® wearable device with built-in 4G cellular connectivity.
0 Comments
Leave a Reply. |